Risk of myocardial infarction following coronary stent implantation without adequate clopidogrel treatment;Akutes herzinfarktrisiko bei mangelnder clopidogrelgabe nach koronarer stentimplantation

Deutsches Arzteblatt

Volumn 103, Issue 43, 2006, Pages

  Silber, Sigmund ^a   Böhm, Michael ^b   Gottwik, Martin ^c   Borggrefe, Martin ^d   Dietz, Rainer ^e  

^a Kardiologische Gemeinschaftspraxis und Praxisklinik   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angioplasty; Clopidogrel; Coronary artery disease; Off label use; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANGIOPLASTY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY STENT; GERMANY; HEALTH INSURANCE; HEART INFARCTION; HUMAN; REVIEW; SURGICAL TECHNIQUE; THROMBOSIS;

EID: 33751541152     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Silber S, Albertsson P, Aviles FF et al.: Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J, 2005; 26: 804-47.
2. Leon MB, Baim DS, Popma JJ et al.: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators (STARS). N Engl J Med, 1998; 339: 1665-71.
3. CARRIE: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CARRIE). Lancet, 1996; 348: 1329-39.
4. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001; 345: 494-502.
5. Mehta SR, Yusuf S, Peters RJ et al.: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001; 358: 527-33.
6. Diener HC, Bogousslavsky J, Brass LM et al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 2004; 364: 331-7.
7. Bhatt DL, Fox KA, Hacke W et al.: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med, 2006; 354: 1706-17.
8. Hall P, Nakamura S, Maiello L et al.: A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation, 1996; 93: 215-22.
9. Schömig A, Neumann FJ, Kastrati A et al.: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med, 1996; 334: 1084-9.
10. Bertrand ME, Legrand V, Boland J et al.: Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation, 1998; 98: 1597-603.
11. Urban P, Macaya C, Rupprecht HJ et al.: Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation, 1998; 98: 2126-32.
12. Cutlip DE, Baim DS, Ho KK et al.: Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation, 2001; 103: 1967-71.
13. Silber S, von Rottkay P, Lössl P et al.: Sicherheit und Durchführbarkeit der intrakoronaren Brachytherapie mit dem Novoste™-System im Rahmen von internationalen Multicenter-Studien. Z Kardiol, 2000; 89: 323-9.
14. Serruys PW, Kutryk MJ, Ong AT: Coronary-artery stents. N Engl J Med, 2006; 354: 483-95.
15. Silber S: Antiproliferativ beschichtete Stents und intrakoronare Brachytherapie: Gemeinsamkeiten und Unterschiede. Z Kardiol, 2002; 91: 443-57.
16. Waksman R, Ajani AE, Pinnow E et al.: Twelve versus six months of ciopidogrei to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation, 2002; 106: 776-8.
17. Iakovou I, Schmidt T, Bonizzoni E et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 2005; 293: 2126-30.
18. McFadden EP, Stabile E, Regar E et al.: Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet, 2004; 364: 1519-21.
19. Feres F, Costa JR Jr., Abizaid A: Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv, 2006; 68: 83-8.
20. Müller I, Seyfarth M, Rüdiger S et al.: Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart, 2001; 85: 92-3.
21. Pfisterer ME: BASKET LATE Trial. late breaking trials, Jahrestagung des American College of Cardiology, ACC, Atlanta, März, 2006.
22. Moreno R, Fernandez C, Hernandez R et al.: Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol, 2005; 45: 954-9.
23. Cosgrave J, Agostoni P, Ge L et al.: Clinical outcome following aleatory implantation of Paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. Am J Cardiol, 2005; 96: 1663-8.
24. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al.: Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. Am J Cardiol, 2006; 97: 38-43.
25. Aoki J, Serruys PW, van Beusekom H et al.: Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) Registry. J Am Coll Cardiol, 2005; 45: 1574-9.